Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Has results × Various Advanced Cancer × Clear all

Phase

Phase 3 2 Phase 2 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 202 Breast Neoplasms 187 Neoplasms 165 Leukemia, Myeloid, Acute 160 Multiple Myeloma 154 Lymphoma 119 Melanoma 115 Neoplasm Metastasis 114 Lymphoma, Non-Hodgkin 110 Prostatic Neoplasms 106 Leukemia 106 Colorectal Neoplasms 95 Recurrence 90 Leukemia, Lymphocytic, Chronic, B-Cell 90 Ovarian Neoplasms 84 Pancreatic Neoplasms 83 Lung Neoplasms 83 Myelodysplastic Syndromes 82 Lymphoma, Follicular 78 Glioblastoma 78 Precursor Cell Lymphoblastic Leukemia-Lymphoma 77 Lymphoma, Large B-Cell, Diffuse 76 Hodgkin Disease 69 Lymphoma, Mantle-Cell 65 Carcinoma, Renal Cell 62 Brain Neoplasms 56 Small Cell Lung Carcinoma 55 Squamous Cell Carcinoma of Head and Neck 54 Triple Negative Breast Neoplasms 52 Sarcoma 52

Interventions

relatlimab 1 daratumumab 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02488759 2023-11-13

CheckMate358

Bristol-Myers Squibb

Phase 1/2 Completed

578 enrolled 19 charts

Various Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡